Ritter Pharmaceuticals is Profiled in this Database

Updated At 30 Apr, 2012

Partial description of this company

First-in-class oral therapeutic to disrupt the natural course of lactose intolerance by stimulating lactose-metabolizing bacteria in the colon and offering long-term symptom relief

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Ritter Pharmaceuticals plus 4858 other startups.

Start Free 7 Day Trial Now

Learn More About Ritter Pharmaceuticals

Technology/product details

Revenue projections

Capital raised to date

Growth strategy